InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Goyitoramo post# 1135

Tuesday, 12/03/2013 11:48:37 AM

Tuesday, December 03, 2013 11:48:37 AM

Post# of 5007
Yes RXII has the potential to do well. It is currently being controlled though right now by NITE and CANT unfortunately. Tomorrow though is Piper Jaffray Healthcare conference, so we might get some trial news on the extended multi dose cohort results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News